Erweiterte Suche

Sbastien Martel ist Chief Financial Officer bei BRP, Inc. Herr Martel war zuvor als Senior Manager bei Arthur Andersen LLP und als Senior Manager bei Deloitte & Touche LLP tätig. Herr Martel hat einen Abschluss der McGill University.

Sébastien Martel is currently the Chief Business Officer at Amicus Therapeutics, Inc. Prior to his current position, he worked at Sanofi as the Vice President-Investor Relations from 2008 to 2020.
Dr. Martel holds a graduate degree, an MBA, and a doctorate from INSEAD.
He also obtained a doctorate from L'Université d'Angers and a graduate degree from Burgundy School of Business.

Frédéric Martel is currently the Chief Executive Officer at Procéthol 2G SAS.
Previously, he worked as an Associé at Innovafonds SAS from 2008 to 2010.

Andre Martel is a member of the International Aluminium Institute and Axor Experts-Conseils, Inc. He was previously the Chief Executive Officer of Tomago Aluminium Co. Pty Ltd., President & Chief Executive Officer of Hydro Aluminium AS, President & Chief Executive Officer of Aluminerie Alouette, Inc., and a member of the Aluminum Association of Canada.
He received an undergraduate degree from the University of Quebec.